Feb 24, 2022 / 07:30PM GMT
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst
Great. Thanks for joining us again. My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team. I also have the privilege of covering animal health. And for our next session, we're joined by Wetteny Joseph, CFO, Zoetis. Wetteny, thanks for being here with us today. We appreciate it.
Wetteny N. Joseph - Zoetis Inc. - Executive VP & CFO
Thanks for having me, Mike. Great to be with you.
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst
I think just to get the ball rolling, you reported 4Q '21 results just last week. Can you give us just a brief recap of some of the key points, both from the quarter and the guide for '22?
Wetteny N. Joseph - Zoetis Inc. - Executive VP & CFO
Yes, I'd be happy to. Mike, in 2021, Zoetis delivered our strongest annual performance
Zoetis Inc at Bank of America Animal Health Summit (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot